PL388252A1 - Terapia skojarzona raka jelita grubego - Google Patents
Terapia skojarzona raka jelita grubegoInfo
- Publication number
- PL388252A1 PL388252A1 PL388252A PL38825209A PL388252A1 PL 388252 A1 PL388252 A1 PL 388252A1 PL 388252 A PL388252 A PL 388252A PL 38825209 A PL38825209 A PL 38825209A PL 388252 A1 PL388252 A1 PL 388252A1
- Authority
- PL
- Poland
- Prior art keywords
- colorectal cancer
- combination therapy
- therapy
- colorectal
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL388252A PL388252A1 (pl) | 2009-06-10 | 2009-06-10 | Terapia skojarzona raka jelita grubego |
US13/375,653 US20120101057A1 (en) | 2009-06-10 | 2010-06-09 | Combined therapy of colorectal carcinoma |
PCT/PL2010/000044 WO2010143986A1 (en) | 2009-06-10 | 2010-06-09 | Combined therapy of colorectal carcinoma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL388252A PL388252A1 (pl) | 2009-06-10 | 2009-06-10 | Terapia skojarzona raka jelita grubego |
Publications (1)
Publication Number | Publication Date |
---|---|
PL388252A1 true PL388252A1 (pl) | 2010-12-20 |
Family
ID=42664756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL388252A PL388252A1 (pl) | 2009-06-10 | 2009-06-10 | Terapia skojarzona raka jelita grubego |
Country Status (3)
Country | Link |
---|---|
US (1) | US20120101057A1 (pl) |
PL (1) | PL388252A1 (pl) |
WO (1) | WO2010143986A1 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL394258A1 (pl) * | 2011-03-18 | 2012-09-24 | Instytut Farmaceutyczny | Terapia skojarzona nowotworów gruczolu sutkowego |
JP2016520572A (ja) | 2013-04-24 | 2016-07-14 | ソーク インスティテュート フォー バイオロジカル スタディーズ | ビタミンd受容体/smadゲノム回路は線維化反応を制御する |
WO2014197680A1 (en) | 2013-06-05 | 2014-12-11 | Salk Institute For Biological Studies | Vitamin d receptor agonists to treat diseases involving cxcl12 activity |
WO2019023149A1 (en) | 2017-07-24 | 2019-01-31 | Salk Institute For Biological Studies | USE OF BROMODOMAIN-CONTAINING PROTEIN-9 ANTAGONISTS IN ASSOCIATION WITH VITAMIN D RECEPTOR AGONISTS IN THE TREATMENT OF DIABETES |
WO2021099901A1 (en) * | 2019-11-19 | 2021-05-27 | Intas Pharmaceuticals Ltd. | Stable topical pharmaceutical composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001034133A2 (en) * | 1999-11-11 | 2001-05-17 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
PL339112A1 (en) | 2000-03-21 | 2001-09-24 | Inst Farmaceutyczny | Pharmacological agent exhibiting aniticarcinogenic effect, application of 1,25-diydoxycholecalcipherol analoques and method of treating neoplasms |
US20020183277A1 (en) * | 2001-05-15 | 2002-12-05 | Lise Binderup | Combination of vitamin D analogue and pyrimidine nucleoside analogue |
BRPI0616330A2 (pt) * | 2005-09-26 | 2011-06-14 | Novacea Inc | prevenÇço e tratamento de distérbios gastrintestinais e da bexiga associados com quimioterapia ou radioterapia usando compostos ativos com vitamina d |
PL378586A1 (pl) | 2005-12-29 | 2007-07-09 | Instytut Farmaceutyczny | Zastosowanie analogów kalcypotriolu w leczeniu chorób nowotworowych |
-
2009
- 2009-06-10 PL PL388252A patent/PL388252A1/pl not_active Application Discontinuation
-
2010
- 2010-06-09 US US13/375,653 patent/US20120101057A1/en not_active Abandoned
- 2010-06-09 WO PCT/PL2010/000044 patent/WO2010143986A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010143986A1 (en) | 2010-12-16 |
US20120101057A1 (en) | 2012-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276362A (en) | Cancer treatment methods | |
IL218575A0 (en) | Treatment of cancer | |
HK1175476A1 (en) | Cancer treatment | |
IL217291A0 (en) | Exosome based treatment of cancer | |
SG10201508495VA (en) | Combination treatment of cancer | |
EP2557923A4 (en) | TREATMENT OF CANCER DISORDERS WITH K-RAS MUTATIONS | |
EP2461814A4 (en) | PROSTATE CANCER TREATMENT | |
IL215764A0 (en) | Adjuvant cancer therapy | |
IL214746A0 (en) | Substituted pyrimidines for the treatment of cancer | |
ZA201107879B (en) | Composition for the treatment of prostate cancer | |
IL213761A0 (en) | Novel ortho-aminoamides for the treatment of cancer | |
HK1189272A1 (zh) | 治療癌症的方法 | |
IL222958A0 (en) | Cancer treatment | |
EP2640390A4 (en) | METHODS OF TREATING CANCER | |
PL388252A1 (pl) | Terapia skojarzona raka jelita grubego | |
EP2585115A4 (en) | ANTICANCER TREATMENT | |
IL215037A0 (en) | Treatment of pancreatic cancer | |
EP2403341A4 (en) | LUNGENKREBSBEHNDLUNG | |
GB0916686D0 (en) | Treatment of cancer | |
EP2473613A4 (en) | KREBSAUSHUNGERUNGSTHERAPIE | |
GB0913603D0 (en) | Cancer therapy | |
GB0921102D0 (en) | Cancer Therapy | |
GB0921757D0 (en) | Treatment of cancer | |
GB201017356D0 (en) | Combination treatment of cancer | |
GB201017354D0 (en) | Treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |